TNF and rheumatoid arthritis: Infliximab (IFX) is an anti-tumor necrosis factor (TNF)-alpha chimeric monoclonal antibody used in the management of autoimmune inflammatory disorders such as rheumatoid arthritis (RA), psoriasis, Crohn’s disease, and inflammatory bowel disease (IBD).